ASHOKA.NSE News

Ashoka Buildcon Limited, a Nashik-based company renowned nationwide for its hallmark trio of quality, innovation, and operational excellence, has been honoured with the prestigious ‘CIA World Award’ series. The company received the award in the Road Construction Projects category as the Best Infrastructure Provider Company, adding another feather to Ashoka Buildcon’s cap.

As part of the final phases of the Mithi River Rejuvenation Project, Package 3 has seen Adani Transport, in collaboration with Ashoka Buildcon and Akshaya Construction through a Special Purpose Vehicle (SPV), emerge as the lowest bidder for Rs 1,700 crore.

Indian markets surged on the new expiry day, erasing recent losses. Strong domestic and global factors fueled the rally. The Nifty is nearing its all-time peak. Companies like Paytm, M&M, Bajaj Auto, Zydus Life, and Ashoka Buildcon are in focus due to significant news. Investors are advised to maintain a positive stance.

In this briefing: HSIE Results Daily: Max Healthcare Institute, Oil India, Ahluwalia Contracts, Ashoka Buildcon Capital Goods - Domestic crane demand continues to recover Ahluwalia Contracts India Ltd - Robust Operating Performance Delivered; Maintain BUY Max Healthcare Institute Ltd - Robust Performance Led by Occupancies Top Conviction Ideas - “Metals & Mining” 1. HSIE Results Daily: Max Healthcare Institute, Oil India, Ahluwalia Contracts, Ashoka Buildcon Max Healthcare Institute: EBITDA^ grew 23% YoY, with 21% YoY sales growth (hospital sales up 22% and Max Labs up 17%) ARPOB grew 1% YoY (+3% growth in existing units), and occupancy was at 76% (vs 79% YoY) Its expansion plan for the next 1-2 years is on track for both brownfield (commissioned 160 beds at Mohali in Q2, to commission 268 beds at Nanavati, Mumbai in mid-Nov 25, and Max Saket 400 beds by Dec 25) and greenfield (Gurgaon 501 in Q4FY26) beds, and margin should be steady for brownfield hospitals (cost synergies) for the next couple of years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

» Smartkarma / by HDFC Securities / Thematic (Sector/Industry) Max Healthcare Institute: EBITDA^ grew 23% YoY, with 21% YoY sales growth (hospital sales up 22% and Max Labs up 17%) ARPOB grew 1% YoY (+3% growth in existing units), and occupancy was at 76% (vs 79% YoY) Its expansion plan for the next 1-2 years is on track for both brownfield (commissioned 160 beds at Mohali in Q2, to commission 268 beds at Nanavati, Mumbai in mid-Nov 25, and Max Saket 400 beds by Dec 25) and greenfield (Gurgaon 501 in Q4FY26) beds, and margin should be steady for brownfield hospitals (cost synergies) for the next couple of years Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. » Get straight to the source on Smartkarma.

ONGC, NHPC, NMDC, Zydus, and Bharat Dynamics, among others, are expected to post their quarterly earnings today. Highway Infrastructure is set to list on the mainboard today.

B2B education platform Crizac lists today.

Ashoka Buildcon shares rose over 5% after receiving LOIs from the Maharashtra Motor Vehicles Department for a 10-year Intelligent Traffic Management System project valued at ₹1,387.19 crore across several regions including Nagpur, Mumbai, and Pune.

Indian shares were muted on Friday, ahead of the Reserve Bank of India’s (RBI) policy announcement, where a rate cut is widely anticipated. The Nifty 50 fell 0.02% to 24,746.95, while the BSE Sensex lost 0.09% to 81,381.77 as of 9:25 a.m. IST. Ten of the 13 major sectors advanced at the open. The broader, more domestically-focussed smallcaps and midcaps gained about 0.3% each. The RBI is expected to cut its key lending rate by 25 basis points for the third consecutive meeting. The policy decision is due at 10:00 a.m. IST. While a 25 basis point rate cut is likely, the policy announcement will be closely watched for commentary on inflation, growth and the future rate path, said Satish Chandra Aluri, analyst at Lemonn Markets Desk. Indian shares rise on optimism over trade negotiations, potential RBI rate cut Other Asian markets were subdued, while Wall Street equities closed lower overnight as a high-profile dispute between U.S. President Donald Trump and billionaire Elon Musk weighed.